Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Theresa Grover

Concepts (345)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
36
2026
279
4.100
Why?
Hernias, Diaphragmatic, Congenital
18
2026
219
3.980
Why?
Extracorporeal Membrane Oxygenation
9
2026
382
1.710
Why?
Infant, Newborn
61
2026
6424
1.610
Why?
Infant, Premature
14
2025
611
1.530
Why?
Catheterization, Central Venous
6
2025
122
1.350
Why?
Cross Infection
3
2025
262
1.300
Why?
Bacterial Infections
2
2025
246
1.250
Why?
Bronchopulmonary Dysplasia
10
2024
410
1.090
Why?
Central Venous Catheters
5
2025
52
1.030
Why?
Urinary Tract Infections
4
2025
202
1.030
Why?
Pulmonary Circulation
15
2011
430
0.910
Why?
Gestational Age
17
2025
975
0.900
Why?
Length of Stay
12
2026
1335
0.880
Why?
Enteral Nutrition
4
2025
216
0.850
Why?
Mycoses
1
2025
88
0.850
Why?
Catheter-Related Infections
4
2017
94
0.750
Why?
Gastroschisis
4
2025
32
0.700
Why?
Quality Improvement
9
2024
1285
0.600
Why?
Catheterization, Peripheral
1
2021
117
0.600
Why?
Hypertension, Pulmonary
11
2021
1980
0.600
Why?
Bottle Feeding
1
2019
19
0.590
Why?
Fetus
14
2020
803
0.580
Why?
Infant
27
2026
10022
0.570
Why?
Infant Formula
1
2019
71
0.560
Why?
Retrospective Studies
33
2026
17009
0.560
Why?
Hospitals, Pediatric
6
2025
555
0.560
Why?
Vascular Endothelial Growth Factor A
6
2007
557
0.550
Why?
Bacteremia
4
2024
221
0.530
Why?
Practice Guidelines as Topic
6
2024
1559
0.530
Why?
Postoperative Complications
5
2025
2916
0.520
Why?
Lung
10
2011
4108
0.510
Why?
Parenteral Nutrition, Total
1
2017
30
0.510
Why?
Vasodilation
11
2011
522
0.490
Why?
Weight Gain
2
2017
556
0.480
Why?
Sheep
20
2011
880
0.480
Why?
Intensive Care, Neonatal
4
2020
42
0.450
Why?
High-Frequency Ventilation
1
2015
45
0.450
Why?
Infant, Premature, Diseases
2
2024
111
0.430
Why?
Intersectoral Collaboration
1
2015
62
0.430
Why?
Developmental Disabilities
1
2018
281
0.430
Why?
Patient Education as Topic
1
2019
777
0.400
Why?
Nitric Oxide Synthase
9
2006
235
0.400
Why?
Tracheostomy
3
2024
142
0.390
Why?
Humans
64
2026
144261
0.380
Why?
Endothelial Growth Factors
2
2002
64
0.380
Why?
Lymphokines
2
2002
130
0.370
Why?
Anti-Bacterial Agents
4
2024
1906
0.370
Why?
Female
54
2026
77976
0.370
Why?
Hospitalization
3
2021
2424
0.360
Why?
Nitric Oxide
10
2011
897
0.350
Why?
Patient Discharge
6
2025
977
0.350
Why?
Surgical Procedures, Operative
1
2014
268
0.340
Why?
Intercellular Signaling Peptides and Proteins
2
2002
381
0.330
Why?
Pulmonary Artery
11
2011
1134
0.320
Why?
Parents
1
2019
1401
0.310
Why?
Intubation, Intratracheal
2
2024
320
0.310
Why?
Respiration, Artificial
6
2026
707
0.300
Why?
Male
33
2026
72035
0.300
Why?
Databases, Factual
7
2025
1484
0.290
Why?
Hospital Mortality
4
2026
1027
0.290
Why?
Persistent Fetal Circulation Syndrome
2
2011
138
0.290
Why?
Anesthesia
2
2023
257
0.290
Why?
Pregnancy
23
2021
7180
0.280
Why?
Survival Rate
4
2018
2088
0.270
Why?
Patient Care Bundles
2
2019
28
0.260
Why?
Lung Diseases
1
2014
787
0.260
Why?
Infant Mortality
2
2026
123
0.250
Why?
Nitric Oxide Synthase Type III
6
2007
204
0.250
Why?
Guideline Adherence
4
2025
586
0.250
Why?
Fibrin
1
2007
91
0.240
Why?
Fetal Diseases
3
2004
191
0.240
Why?
Intestinal Atresia
1
2025
17
0.230
Why?
Urea Cycle Disorders, Inborn
1
2026
26
0.230
Why?
Hernia, Diaphragmatic
1
2026
67
0.230
Why?
Jejunum
1
2025
35
0.230
Why?
Hospitals, High-Volume
1
2026
49
0.230
Why?
Guanylate Cyclase
4
2011
39
0.230
Why?
Multivariate Analysis
5
2025
1533
0.230
Why?
Logistic Models
6
2025
2104
0.230
Why?
Heart Defects, Congenital
2
2026
913
0.230
Why?
Pulmonary Alveoli
2
2005
383
0.230
Why?
Infection Control
2
2017
171
0.220
Why?
Ileum
1
2025
111
0.220
Why?
Bradycardia
2
2024
59
0.220
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
297
0.220
Why?
Anastomotic Leak
1
2024
44
0.210
Why?
Ductus Arteriosus, Patent
1
2025
50
0.210
Why?
Ventilator Weaning
1
2024
39
0.210
Why?
Consensus
2
2024
488
0.210
Why?
Esophageal Atresia
1
2024
30
0.210
Why?
Device Removal
1
2025
142
0.210
Why?
North America
1
2025
310
0.210
Why?
Stenosis, Pulmonary Vein
1
2024
19
0.210
Why?
Tracheoesophageal Fistula
1
2024
38
0.210
Why?
Blood Culture
1
2024
25
0.210
Why?
Critical Pathways
1
2025
106
0.210
Why?
Cyclic GMP
4
2011
92
0.200
Why?
Clinical Protocols
1
2025
282
0.200
Why?
Severity of Illness Index
6
2026
2917
0.200
Why?
Laryngoscopy
1
2024
117
0.200
Why?
Ductus Arteriosus
6
2008
72
0.190
Why?
Neovascularization, Pathologic
1
2004
286
0.190
Why?
Delphi Technique
1
2024
329
0.180
Why?
Hemangioendothelioma
1
2002
13
0.180
Why?
Infant, Newborn, Diseases
1
2023
113
0.180
Why?
Infant, Small for Gestational Age
2
2025
109
0.170
Why?
Time Factors
7
2024
7155
0.170
Why?
Uterus
1
2002
226
0.170
Why?
Patient Handoff
1
2021
42
0.170
Why?
Retrognathia
1
2020
4
0.170
Why?
Hepatitis B Vaccines
1
2021
43
0.170
Why?
Animals, Newborn
7
2009
901
0.160
Why?
Micrognathism
1
2020
19
0.160
Why?
Neuromuscular Blockade
1
2021
51
0.160
Why?
Hepatitis B
1
2021
66
0.160
Why?
Betamethasone
1
2000
21
0.160
Why?
Benzoates
2
2011
50
0.160
Why?
Social Determinants of Health
1
2024
299
0.160
Why?
Analgesia
1
2021
105
0.160
Why?
Vascular Resistance
6
2011
366
0.160
Why?
Ventricular Septum
1
2019
8
0.150
Why?
Carbon Monoxide
1
2000
82
0.150
Why?
Incidence
2
2018
2870
0.150
Why?
Hypothermia
1
2020
52
0.150
Why?
United States
7
2025
15876
0.150
Why?
Cooperative Behavior
3
2017
462
0.150
Why?
Food, Fortified
1
2019
44
0.150
Why?
Geographic Mapping
1
2019
29
0.140
Why?
Neonatology
1
2019
28
0.140
Why?
Blood Pressure
5
2019
1759
0.140
Why?
Airway Obstruction
1
2020
162
0.140
Why?
Receptors, Cytoplasmic and Nuclear
2
2011
209
0.140
Why?
Endothelium, Vascular
1
2005
963
0.140
Why?
Recombinant Proteins
4
2005
1367
0.140
Why?
Animals
22
2011
38030
0.140
Why?
Community-Acquired Infections
1
2020
174
0.140
Why?
Respiratory Insufficiency
1
2021
326
0.140
Why?
Housing
1
2019
144
0.130
Why?
Echocardiography, Doppler
1
2018
115
0.130
Why?
Perioperative Care
1
2020
230
0.130
Why?
Odds Ratio
2
2020
1072
0.130
Why?
Cardiopulmonary Resuscitation
1
2020
340
0.130
Why?
Infant, Very Low Birth Weight
1
2017
73
0.120
Why?
Continuity of Patient Care
1
2019
287
0.120
Why?
Premature Birth
1
2020
380
0.120
Why?
Heart Arrest
1
2020
407
0.120
Why?
Echocardiography
1
2019
647
0.120
Why?
Infant, Extremely Premature
1
2017
67
0.120
Why?
Patient Readmission
2
2019
756
0.120
Why?
Disease Models, Animal
6
2011
4556
0.120
Why?
Patient Transfer
1
2019
206
0.120
Why?
Hemodynamics
6
2011
1119
0.120
Why?
Glucocorticoids
1
2000
533
0.120
Why?
Child
8
2023
22537
0.120
Why?
Antimicrobial Stewardship
1
2018
129
0.120
Why?
Risk Adjustment
1
2016
85
0.110
Why?
Vasoconstriction
2
2008
217
0.110
Why?
Clinical Nursing Research
1
2015
13
0.110
Why?
Ligation
3
2025
92
0.110
Why?
Liver Neoplasms
1
2002
780
0.110
Why?
Communication
1
2021
961
0.110
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
3
2011
28
0.110
Why?
Enterocolitis, Necrotizing
2
2024
41
0.100
Why?
Enzyme Activation
3
2005
765
0.100
Why?
Nitroarginine
5
2006
57
0.100
Why?
rho-Associated Kinases
3
2011
83
0.100
Why?
Pregnancy Complications, Cardiovascular
2
2004
83
0.100
Why?
Premedication
2
2024
42
0.100
Why?
Program Evaluation
1
2017
946
0.100
Why?
Vascular Endothelial Growth Factors
2
2002
80
0.090
Why?
Linear Models
2
2025
850
0.090
Why?
Heart Septal Defects, Ventricular
2
2026
46
0.090
Why?
Administration, Inhalation
2
2007
574
0.090
Why?
Mothers
1
2019
774
0.090
Why?
Isoenzymes
2
2011
299
0.090
Why?
Vasodilator Agents
2
2011
331
0.090
Why?
Pneumonia
1
2018
630
0.090
Why?
Apgar Score
2
2023
20
0.090
Why?
Enzyme Inhibitors
5
2009
824
0.080
Why?
Leadership
1
2015
408
0.080
Why?
Health Services Accessibility
1
2019
1091
0.080
Why?
Sulfones
3
2005
127
0.080
Why?
Pyridines
4
2011
605
0.080
Why?
Infant, Low Birth Weight
2
2022
153
0.080
Why?
Chronic Disease
2
2014
1812
0.080
Why?
Prevalence
3
2024
2815
0.080
Why?
Myocytes, Smooth Muscle
1
2011
266
0.080
Why?
Treatment Outcome
5
2025
11643
0.070
Why?
Serotonin
1
2011
293
0.070
Why?
Risk Factors
4
2025
10699
0.070
Why?
Magnetic Resonance Imaging
1
2022
3857
0.070
Why?
Pulmonary Wedge Pressure
2
2009
67
0.070
Why?
Amides
2
2006
101
0.070
Why?
Cohort Studies
4
2021
5935
0.070
Why?
Muscle, Smooth, Vascular
3
2009
452
0.070
Why?
Immunohistochemistry
2
2002
1715
0.070
Why?
Procollagen-Proline Dioxygenase
1
2007
27
0.060
Why?
Estradiol
2
2001
533
0.060
Why?
Immediate-Early Proteins
1
2007
48
0.060
Why?
Cardiovascular Agents
1
2008
163
0.060
Why?
Oxadiazoles
3
2011
37
0.060
Why?
Comorbidity
2
2024
1646
0.060
Why?
Case-Control Studies
2
2024
3592
0.060
Why?
Hospitals, Low-Volume
1
2026
25
0.060
Why?
Selenium
1
2025
49
0.060
Why?
Hydroxyeicosatetraenoic Acids
1
2005
35
0.060
Why?
Renal Replacement Therapy
1
2026
99
0.060
Why?
Protein Kinase Inhibitors
2
2008
968
0.050
Why?
Thoracoscopy
1
2024
62
0.050
Why?
Chylothorax
1
2024
20
0.050
Why?
Abnormalities, Multiple
1
2026
197
0.050
Why?
Antibiotic Prophylaxis
1
2025
129
0.050
Why?
Hyperoxia
1
2005
99
0.050
Why?
Pyrazoles
2
2005
509
0.050
Why?
Anastomosis, Surgical
1
2024
157
0.050
Why?
Birth Weight
1
2007
522
0.050
Why?
Continuous Positive Airway Pressure
1
2024
88
0.050
Why?
Body Weight
2
2005
976
0.050
Why?
Noninvasive Ventilation
1
2024
62
0.050
Why?
Video Recording
1
2024
211
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
459
0.050
Why?
Parenteral Nutrition
1
2024
105
0.050
Why?
Homeodomain Proteins
1
2007
523
0.050
Why?
Chromones
1
2002
42
0.050
Why?
Platelet-Derived Growth Factor
1
2003
90
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2002
109
0.050
Why?
Acetaminophen
1
2025
264
0.050
Why?
Morpholines
1
2002
128
0.050
Why?
Clinical Trials as Topic
1
2007
1050
0.040
Why?
Airway Extubation
1
2022
60
0.040
Why?
Oligonucleotides
1
2002
149
0.040
Why?
Drug Administration Schedule
2
2001
778
0.040
Why?
Gastroesophageal Reflux
1
2024
236
0.040
Why?
Prostaglandins
1
2001
94
0.040
Why?
Estrogen Antagonists
1
2001
48
0.040
Why?
Artifacts
1
2022
139
0.040
Why?
Respiration
1
2022
206
0.040
Why?
Cardiac Catheterization
1
2025
557
0.040
Why?
Soluble Guanylyl Cyclase
2
2011
16
0.040
Why?
Image Enhancement
1
2022
199
0.040
Why?
Piperazines
3
2011
380
0.040
Why?
Postoperative Period
1
2021
353
0.040
Why?
Dose-Response Relationship, Drug
3
2011
2026
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2002
379
0.040
Why?
Protoporphyrins
1
2000
14
0.040
Why?
Injections, Intra-Arterial
1
2000
26
0.040
Why?
Prognosis
2
2019
4278
0.040
Why?
Epinephrine
1
2020
155
0.040
Why?
Quinoxalines
2
2011
65
0.040
Why?
Perioperative Period
1
2020
71
0.040
Why?
Benzodiazepines
1
2021
165
0.040
Why?
Injections, Intramuscular
1
2000
141
0.040
Why?
Airway Management
1
2020
79
0.040
Why?
Proteus
1
2019
6
0.040
Why?
Enterobacter
1
2019
8
0.040
Why?
Pain Management
1
2023
405
0.040
Why?
DNA-Binding Proteins
1
2007
1497
0.040
Why?
Transportation of Patients
1
2020
68
0.040
Why?
Colorado
2
2020
4562
0.040
Why?
Aftercare
1
2021
220
0.040
Why?
Body Temperature Regulation
1
2020
107
0.040
Why?
Body Temperature
1
2020
228
0.040
Why?
Hypnotics and Sedatives
1
2021
214
0.040
Why?
Contrast Media
1
2022
486
0.040
Why?
RNA, Messenger
1
2007
2829
0.040
Why?
Reference Values
1
2000
797
0.040
Why?
Benchmarking
1
2020
188
0.040
Why?
Blood Vessels
1
2000
171
0.030
Why?
Ultrasonography, Prenatal
1
2020
294
0.030
Why?
Receptors, Estrogen
1
2001
457
0.030
Why?
Surgical Mesh
1
2018
50
0.030
Why?
Infectious Disease Transmission, Vertical
1
2020
187
0.030
Why?
Cesarean Section
1
2000
224
0.030
Why?
Operating Rooms
1
2020
146
0.030
Why?
Imaging, Three-Dimensional
1
2022
582
0.030
Why?
Sterilization
1
2017
24
0.030
Why?
Program Development
1
2020
369
0.030
Why?
Drug Utilization
1
2018
166
0.030
Why?
Congenital Abnormalities
1
2018
104
0.030
Why?
Diagnosis, Differential
1
2002
1487
0.030
Why?
Gene Expression Regulation, Developmental
1
2002
905
0.030
Why?
Hydrogen-Ion Concentration
1
2018
561
0.030
Why?
Risk Assessment
2
2018
3637
0.030
Why?
Acetylcholine
2
2009
204
0.030
Why?
Regression Analysis
1
2018
998
0.030
Why?
Patient Care Team
1
2021
686
0.030
Why?
3',5'-Cyclic-GMP Phosphodiesterases
2
2005
17
0.030
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
2
2005
23
0.030
Why?
Sildenafil Citrate
2
2005
60
0.030
Why?
Staphylococcus aureus
1
2019
454
0.030
Why?
Burns
1
2020
376
0.030
Why?
Escherichia coli
1
2019
852
0.030
Why?
Prenatal Exposure Delayed Effects
1
2001
674
0.030
Why?
Purines
2
2005
187
0.030
Why?
Survival Analysis
1
2017
1382
0.020
Why?
Cells, Cultured
2
2011
4146
0.020
Why?
Vaccination
1
2021
1422
0.020
Why?
Analgesics, Opioid
1
2021
1131
0.020
Why?
Ketanserin
1
2011
12
0.020
Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
10
0.020
Why?
Hysterotomy
1
2011
9
0.020
Why?
Sertraline
1
2011
27
0.020
Why?
Receptors, Serotonin
1
2011
35
0.020
Why?
Prostaglandin-Endoperoxide Synthases
2
2001
74
0.020
Why?
Nitroprusside
1
2011
72
0.020
Why?
Fluoxetine
1
2011
54
0.020
Why?
Hypertrophy, Right Ventricular
2
2003
150
0.020
Why?
Kidney
1
2018
1495
0.020
Why?
Adrenal Cortex Hormones
1
2013
478
0.020
Why?
Hydrogen Peroxide
1
2011
336
0.020
Why?
Prospective Studies
1
2021
7970
0.020
Why?
Constriction
1
2008
47
0.020
Why?
Indoles
1
2011
501
0.020
Why?
Signal Transduction
3
2006
5221
0.020
Why?
Child, Preschool
1
2022
11774
0.020
Why?
Regional Blood Flow
1
2008
512
0.010
Why?
Phosphoric Diester Hydrolases
1
2004
53
0.010
Why?
Organ Size
1
2005
462
0.010
Why?
Heart Atria
1
2004
144
0.010
Why?
Drug Combinations
1
2005
390
0.010
Why?
Neovascularization, Physiologic
1
2005
194
0.010
Why?
Blood Flow Velocity
1
2004
413
0.010
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
31
0.010
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2003
54
0.010
Why?
Meclofenamic Acid
1
2001
9
0.010
Why?
8-Bromo Cyclic Adenosine Monophosphate
1
2001
20
0.010
Why?
Aorta
1
2004
429
0.010
Why?
Cyclooxygenase 1
1
2001
26
0.010
Why?
Infusions, Intra-Arterial
1
2001
61
0.010
Why?
Cyclooxygenase Inhibitors
1
2001
81
0.010
Why?
Intramolecular Oxidoreductases
1
2001
66
0.010
Why?
Pulmonary Ventilation
1
2001
83
0.010
Why?
Cyclooxygenase 2
1
2001
165
0.010
Why?
Organ Specificity
1
2001
312
0.010
Why?
Ligands
1
2003
673
0.010
Why?
Cytochrome P-450 Enzyme System
1
2001
162
0.010
Why?
Drug Interactions
1
2001
397
0.010
Why?
Physical Stimulation
1
2000
68
0.010
Why?
Rats, Sprague-Dawley
1
2005
2525
0.010
Why?
Stress, Mechanical
1
2001
494
0.010
Why?
Muscle, Smooth
1
2000
151
0.010
Why?
Blotting, Western
1
2001
1187
0.010
Why?
Gene Expression
1
2003
1487
0.010
Why?
Rats
1
2005
5592
0.010
Why?
Grover's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)